CAS: 1231220-79-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LY2828360 REF: IN-DA01EONJCAS: 1231220-79-3 | 98% | To inquire | Tue 07 Jan 25 |
 | LY2828360 REF: TM-T7316CAS: 1231220-79-3 | 98.45% - 99.51% | 43.00 €~291.00 € | Tue 14 Jan 25 |
 | LY2828360 REF: 3D-GZB22079CAS: 1231220-79-3 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01EONJ
| 5mg | 285.00 € | ||
| 10mg | 637.00 € | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
LY2828360
CAS:1231220-79-3
LY2828360: CB2 agonist, Ki=40.3 nM; biases CB2 over CB1 with EC50s of 20.1 nM and …
Formula:
C22H27ClN6O
Purity:
98.45% - 99.51%
Color and Shape:
Solid
Molecular weight:
426.94
Ref: TM-T7316
| 2mg | 43.00 € | ||
| 5mg | 51.00 € | ||
| 10mg | 83.00 € | ||
| 25mg | 142.00 € | ||
| 50mg | 198.00 € | ||
| 100mg | 291.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
LY2828360
CAS:1231220-79-3
LY2828360 is a low-potency cannabinoid receptor agonist that has been shown to antagonize the effects …
Formula:
C22H27ClN6O
Purity:
Min. 95%
Molecular weight:
426.94 g/mol
Ref: 3D-GZB22079
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
